Martin Krátký

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Future medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Biomolecules

Charles University, Faculty of Pharmacy in Hradec Kralove (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Charles University, Faculty of Pharmacy in Hradec Kralove Feb 10 2012

Czechia

PHD :: Department of Organic and Bioorganic Chemistry

Publications

Martin Krátký
Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureus . Future medicinal chemistry (2024)
Martin Krátký
Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureus . Future medicinal chemistry 16 (6) (2024)
Martin Krátký
Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureus . Future medicinal chemistry 16 (6) (2024)
Martin Krátký
Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureus . Future medicinal chemistry 16 (6) (2024)
Martin Krátký, Klára Konečná, Adéla Šimková, Ondřej Janďourek, Jana Maixnerová, Jiřina Stolaříková, Marcela Vejsová, Barbora Voxová, Frantisek Trejtnar, Jarmila Vinšová
Improving the antimicrobial activity of old antibacterial drug mafenide: Schiff bases and their bioactivity targeting resistant pathogens. Future medicinal chemistry (2023)
Václav Pflégr, Jiřina Stolaříková, Adrián Pál, Jana Korduláková, Martin Krátký
Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents. Future medicinal chemistry (2023)
Martin Krátký, Klára Konečná, Adéla Šimková, Ondřej Janďourek, Jana Maixnerová, Jiřina Stolaříková, Marcela Vejsová, Barbora Voxová, Frantisek Trejtnar, Jarmila Vinšová
Improving the antimicrobial activity of old antibacterial drug mafenide: Schiff bases and their bioactivity targeting resistant pathogens. Future medicinal chemistry 15 (3) (2023)
Martin Krátký, Klára Konečná, Adéla Šimková, Ondřej Janďourek, Jana Maixnerová, Jiřina Stolaříková, Marcela Vejsová, Barbora Voxová, Frantisek Trejtnar, Jarmila Vinšová
Improving the antimicrobial activity of old antibacterial drug mafenide: Schiff bases and their bioactivity targeting resistant pathogens. Future medicinal chemistry 15 (3) (2023)
Neto-Honorius Houngbedji, Sarka Stepankova, Václav Pflégr, Katarina Vorčáková, Markéta Švarcová, Jarmila Vinšová, Martin Krátký
Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Martin Krátký, Karolína Nováčková, Katarína Svrčková, Markéta Švarcová, Sarka Stepankova
New 3-amino-2-thioxothiazolidin-4-one-based inhibitors of acetyl- and butyryl-cholinesterase: synthesis and activity. Future medicinal chemistry (2023)
Václav Pflégr, Sarka Stepankova, Katarina Vorčáková, Markéta Švarcová, Jarmila Vinšová, Martin Krátký
5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Martin Krátký, Klára Konečná, Jiří Janoušek, Ondřej Janďourek, Jana Maixnerová, Sára Kalivodová, Frantisek Trejtnar, Jarmila Vinšová
Sulfonamide-salicylaldehyde imines active against methicillin- and trimethoprim/sulfonamide-resistant Staphylococci. Future medicinal chemistry 13 (22) (2021)
Martin Krátký, Katarina Vorčáková, Quynh Anh Vu, Sarka Stepankova, Jarmila Vinšová
Hydrazones of 4-(Trifluoromethyl)benzohydrazide as New Inhibitors of Acetyl- and Butyrylcholinesterase. Molecules (Basel, Switzerland) 26 (4) (2021)
Martin Krátký, Sarka Stepankova, Klára Konečná, Katarina Vorčáková, Jana Maixnerová, Markéta Švarcová, Ondřej Janďourek, František Trejtnar, Jarmila Vinšová
Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Václav Pflégr, Jana Maixnerová, Jiřina Stolaříková, Adrián Pál, Jana Korduláková, Frantisek Trejtnar, Jarmila Vinšová, Martin Krátký
Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Martin Krátký, Zsuzsa Baranyai, Sarka Stepankova, Katarína Svrčková, Markéta Švarcová, Jiřina Stolaříková, Lilla Horváth, Szilvia Erika Bősze, Jarmila Vinšová
N-Alkyl-2-[4-(trifluoromethyl)benzoyl]hydrazine-1-carboxamides and Their Analogues: Synthesis and Multitarget Biological Activity. Molecules (Basel, Switzerland) 25 (10) (2020)
Martin Krátký, Sarka Stepankova, Neto-Honorius Houngbedji, Rudolf Vosátka, Katarina Vorčáková, Jarmila Vinšová
2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase. Biomolecules 9 (11) (2019)

Martin Krátký.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Krátký